in vivo delivery from study to gene therapy: overview, considerations and challenges
Tuesday, June 18, 2019
18:00 to 19:00 CEST (Berlin, Paris, Madrid)
in vivo transfection is a non-viral method to deliver nucleic acids directly into an animal or in Human.
This technique can be used for in vivo proof of concept studies up to Gene Therapy. To successfully deliver nucleic acids into a specific organ, it is important to understand how in vivo transfection can be performed and what the limitations of this technique are. As delivery experts, Polyplus-transfection gives an overview of the in vivo delivery methods and delves into key considerations and challenges that come with in vivo experimentation.
With this webinar, you will acquire an understanding of:
- in vivo delivery methods to generate an animal model
- key parameters to consider when choosing an approach
- how to address in vivo delivery challenges
Alengo Nyamay'antu, PhD
Alengo Nyamay’antu is Scientific Support and Communication Specialist at Polyplus-transfection® SA, a leading biotechnology company that provides solutions for delivery of nucleic acids in research, bioproduction and therapeutics. Alengo completed her MSc in structural and functional biochemistry at the University of Lyon and went on to specialise in protein biochemistry at the University of Manchester. She then continued to develop and widen her scientific and communication skills by joining the Max Planck Institute for Biomedicine as a postdoctoral researcher. Alengo is particularly keen on exchanging and discussing science, and looks forward to the upcoming webinar to get you started on genome editing with the latest technologies.